Anti-CLEC2D antibody [EPR27404-37],Abcam,AB309147

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human

Application

WB, ICC/IF, IP

Platform ID

BAB764367394

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-CLEC2D antibody [EPR27404-37]
Cat. No.AB309147
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB, ICC/IF, IP
ClonalityMonoclonal
Clone NumberEPR27404-37
Concentration0.494 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis (PubMed : 16339513, PubMed : 20843815). Inhibits osteoclast formation (PubMed : 14753741, PubMed : 15123656). Inhibits bone resorption (PubMed : 14753741). Modulates the release of interferon-gamma (PubMed : 15104121). Binds high molecular weight sulfated glycosaminoglycans (PubMed : 15123656). See full target information CLEC2D

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.